Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-24

Clinical Trial Update: A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety and efficacy of lacosamide in painful diabetic neuropathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Painful Diabetic Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2023-07-24